Our clinical trials address treatment gaps in traumatic brain injury (TBI)-related symptomatology, such as:
- Post-traumatic Stress (PTS)
Current treatments for these symptoms are only moderately effective, which threatens the health, readiness, and competitive edge of our nation’s Armed Forces. Our trials expand upon our previous research to narrow knowledge gaps and improve TBI treatment guidelines.
Our clinical trials apply novel pharmacologic and non-pharmacologic treatment approaches to a variety of symptoms across multiple timespans. Exerting the most rigorous standards, our trials are multicenter, randomized, double-blinded, and placebo controlled. Treatments include, but are not limited to:
- External stimulation devices (e.g. transcranial magnetic stimulation and light therapy)
- Digital therapeutics for the deployment of Cognitive Behavioral Therapy
- Behavioral Therapies
- Reconditioning therapies
- Cognitive Behavioral Therapy
Our trials also vary by design. This diverse repertoire ensures each trial is customized for distinct populations and environments. Our trial designs include:
- On-site trials
- Ongoing or upcoming research within the Washington D.C. area
- Multi-center studies conducted at several large Military Treatment Facilities in the U.S.
- Remote Trials
- Conducted entirely by telephone, internet, or mail with online consent capabilities
- Direct data entry with patient completed collection through the use of internet accessed surveys and questionnaires
- A hybrid in-person study design model that can accommodate partial to full remote activities
Clinical trials require a multifaceted and integrated approach. Our trials are supported by our in-house Clinical Trials Unit, Clinical Core Facilities, and Research Support teams. Below is an overview of our trial portfolio.